UFT-induced haemolytic anaemia.
A case of haemolytic anaemia in a patient under treatment with UFT for metastatic colon cancer is reported. Haemolytic anaemia has previously been associated with many other chemotherapeutic agents, but not with UFT, an oral anticancer agent combining tegafur (Ftorafur, a prodrug of 5-fluorouracil) and uracil.